{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/41126"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/41126","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"The role of transmembrane immunoglobulin domain containing-1 in colon cancer","abstract":"Colorectal Cancer (CRC) is one of the most common cancers worldwide. Although various genetic and environmental mechanisms have been identified, the full molecular mechanisms deriving CRC tumorigenesis remain largely unknown. Transmembrane and Immunoglobulin Domain Containing-1 (TMIGD1) is a newly identified candidate tumor suppressor that is mainly expressed in the kidneys and intestines. However, whether TMIGD1 is involved in the tumorigenesis of CRC is not currently known. The main objective of this project was to investigate the effects of the loss of TMIGD1 on intestinal morphology and cellular differentiation in wildtype and knockout mice. Our findings illustrate that the loss of TMIGD1 causes intestinal adenomas and disrupts intestinal brush border formation in mouse models. Furthermore, our research shows that the loss of TMIGD1 in mice affects cellular maturation and intestinal epithelium differentiation. We also demonstrate that TMIGD1 is downregulated in human CRC tissue. Taken together, our results reveal that the loss of TMIGD1 in mouse colonic epithelium results in impaired intestinal epithelium brush border formation, junctional polarity, and development of colonic adenoma.","abstract_html":"Colorectal Cancer (CRC) is one of the most common cancers worldwide. Although various genetic and environmental mechanisms have been identified, the full molecular mechanisms deriving CRC tumorigenesis remain largely unknown. Transmembrane and Immunoglobulin Domain Containing-1 (TMIGD1) is a newly identified candidate tumor suppressor that is mainly expressed in the kidneys and intestines. However, whether TMIGD1 is involved in the tumorigenesis of CRC is not currently known. The main objective of this project was to investigate the effects of the loss of TMIGD1 on intestinal morphology and cellular differentiation in wildtype and knockout mice. Our findings illustrate that the loss of TMIGD1 causes intestinal adenomas and disrupts intestinal brush border formation in mouse models. Furthermore, our research shows that the loss of TMIGD1 in mice affects cellular maturation and intestinal epithelium differentiation. We also demonstrate that TMIGD1 is downregulated in human CRC tissue. Taken together, our results reveal that the loss of TMIGD1 in mouse colonic epithelium results in impaired intestinal epithelium brush border formation, junctional polarity, and development of colonic adenoma.","abstract_has_math":false,"creators":["de la Cena, Kyle Oliver"],"institution":"Boston University","degree_name":"Master of Science","degree_level":"masters","degree_discipline":"Pathology","degree_department":null,"school":null,"contributors":[],"advisors":["Rahimi, Nader"],"committee_chairs":[],"committee_members":[],"year":2020,"date_issued":"2020","date_published":"2020","updated_at":"2026-11-19T02:41:25Z","subjects":["Biology","Colorectal cancer","TMIGD1"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[{"key":"dc:identifier.orcid","label":"ORCID","values":["0000-0002-8609-7223"],"render_values":[{"text":"0000-0002-8609-7223","href":"https://orcid.org/0000-0002-8609-7223","code":true}]}]},"links":{"outbound_url":"https://hdl.handle.net/2144/41126","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/41126","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F41126","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Rahimi, Nader"]},{"key":"dc:creator","label":"Author","values":["de la Cena, Kyle Oliver"]},{"key":"dc:identifier.orcid","label":"ORCID","values":["0000-0002-8609-7223"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2020-06-05T12:37:48Z"]},{"key":"dc:date.embargo","label":"Dc Date Embargo","values":["2021-06-04T00:00:00Z"]},{"key":"dc:date.issued","label":"Date","values":["2020"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2020-06-04T16:09:34Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Pathology"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Biology","Colorectal cancer","TMIGD1"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/41126"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Colorectal Cancer (CRC) is one of the most common cancers worldwide. Although various genetic and environmental mechanisms have been identified, the full molecular mechanisms deriving CRC tumorigenesis remain largely unknown. Transmembrane and Immunoglobulin Domain Containing-1 (TMIGD1) is a newly identified candidate tumor suppressor that is mainly expressed in the kidneys and intestines. However, whether TMIGD1 is involved in the tumorigenesis of CRC is not currently known. The main objective of this project was to investigate the effects of the loss of TMIGD1 on intestinal morphology and cellular differentiation in wildtype and knockout mice. Our findings illustrate that the loss of TMIGD1 causes intestinal adenomas and disrupts intestinal brush border formation in mouse models. Furthermore, our research shows that the loss of TMIGD1 in mice affects cellular maturation and intestinal epithelium differentiation. We also demonstrate that TMIGD1 is downregulated in human CRC tissue. Taken together, our results reveal that the loss of TMIGD1 in mouse colonic epithelium results in impaired intestinal epithelium brush border formation, junctional polarity, and development of colonic adenoma."]},{"key":"dc:title","label":"Title","values":["The role of transmembrane immunoglobulin domain containing-1 in colon cancer"]}]}],"canonical_facts":{"dc:contributor.advisor":["Rahimi, Nader"],"dc:creator":["de la Cena, Kyle Oliver"],"dc:date.accessioned":["2020-06-05T12:37:48Z"],"dc:date.embargo":["2021-06-04T00:00:00Z"],"dc:date.issued":["2020"],"dc:date.updated":["2020-06-04T16:09:34Z"],"dc:description.abstract":["Colorectal Cancer (CRC) is one of the most common cancers worldwide. Although various genetic and environmental mechanisms have been identified, the full molecular mechanisms deriving CRC tumorigenesis remain largely unknown. Transmembrane and Immunoglobulin Domain Containing-1 (TMIGD1) is a newly identified candidate tumor suppressor that is mainly expressed in the kidneys and intestines. However, whether TMIGD1 is involved in the tumorigenesis of CRC is not currently known. The main objective of this project was to investigate the effects of the loss of TMIGD1 on intestinal morphology and cellular differentiation in wildtype and knockout mice. Our findings illustrate that the loss of TMIGD1 causes intestinal adenomas and disrupts intestinal brush border formation in mouse models. Furthermore, our research shows that the loss of TMIGD1 in mice affects cellular maturation and intestinal epithelium differentiation. We also demonstrate that TMIGD1 is downregulated in human CRC tissue. Taken together, our results reveal that the loss of TMIGD1 in mouse colonic epithelium results in impaired intestinal epithelium brush border formation, junctional polarity, and development of colonic adenoma."],"dc:identifier.orcid":["0000-0002-8609-7223"],"dc:identifier.uri":["https://hdl.handle.net/2144/41126"],"dc:language.iso":["en_US"],"dc:subject":["Biology","Colorectal cancer","TMIGD1"],"dc:title":["The role of transmembrane immunoglobulin domain containing-1 in colon cancer"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Pathology"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Science"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-19T02:41:25Z"}